BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest 8-A12G SEC Filings
Registration of securities [Section 12(g)]

GENZYME CORP, 8-A12G, 2000-12-19
TRANSKARYOTIC THERAPIES INC, 8-A12G, 2000-12-14
THIRD WAVE TECHNOLOGIES INC /WI, 8-A12G, 2000-10-11
ARIAD PHARMACEUTICALS INC, 8-A12G, 2000-06-19
CURIS INC, 8-A12G, 2000-04-13
DRUGABUSE SCIENCES INC, 8-A12G, 2000-03-28
ANTIGENICS INC /DE/, 8-A12G, 2000-01-24
BIOPURE CORP, 8-A12G, 1999-11-04
SEROLOGICALS CORP, 8-A12G, 1999-08-10
ABGENIX INC, 8-A12G, 1999-06-15
GENZYME CORP, 8-A12G, 1999-06-11
BIOGEN INC, 8-A12G, 1999-05-06
GENZYME CORP, 8-A12G, 1999-03-25
CLONTECH LABORATORIES INC, 8-A12G, 1999-03-03
INVITROGEN CORP, 8-A12G, 1999-01-29
BIOTIME INC, 8-A12G, 1998-12-18
LA JOLLA PHARMACEUTICAL CO, 8-A12G, 1998-12-04
MEDIMMUNE INC /DE, 8-A12G, 1998-12-01
VION PHARMACEUTICALS INC, 8-A12G, 1998-10-26
CYTOTHERAPEUTICS INC/DE, 8-A12G, 1998-08-03
V I TECHNOLOGIES INC, 8-A12G, 1998-05-13
BIOTIME INC, 8-A12G, 1998-05-13
ABGENIX INC, 8-A12G, 1998-05-05
AVIRON, 8-A12G, 1998-04-21
APHTON CORP, 8-A12G, 1998-01-30
APOLLON INC, 8-A12G, 1997-12-12
CORIXA CORP, 8-A12G, 1997-09-22
NABI /DE/, 8-A12G, 1997-08-29
PROGENITOR INC, 8-A12G, 1997-07-30
MEDIMMUNE INC /DE, 8-A12G, 1997-07-09
GLIATECH INC, 8-A12G, 1997-07-02
GENZYME CORP, 8-A12G, 1997-06-18
NEUROCRINE BIOSCIENCES INC, 8-A12G, 1997-06-16
CYTRX CORP, 8-A12G, 1997-04-17
TRANSCEND THERAPEUTICS INC, 8-A12G, 1997-04-15
ORAVAX INC /DE/, 8-A12G, 1997-04-11
AVAX TECHNOLOGIES INC, 8-A12G, 1997-04-04
MEDAREX INC, 8-A12G, 1997-02-26
BIOTIME INC, 8-A12G, 1997-01-10
CERUS CORP, 8-A12G, 1997-01-08
NPS PHARMACEUTICALS INC, 8-A12G, 1996-12-31
CYPRESS BIOSCIENCE INC, 8-A12G, 1996-11-04
INGENEX INC, 8-A12G, 1996-10-22
TARGETED GENETICS CORP /WA/, 8-A12G, 1996-10-22
SPARTA PHARMACEUTICALS INC, 8-A12G, 1996-10-17
AVIRON, 8-A12G, 1996-10-10
TRANSKARYOTIC THERAPIES INC, 8-A12G, 1996-10-04
PROGENITOR INC, 8-A12G, 1996-08-16
LIPOSOME CO INC, 8-A12G, 1996-07-12
LIFECORE BIOMEDICAL INC, 8-A12G, 1996-05-31
VIRUS RESEARCH INSTITUTE INC, 8-A12G, 1996-05-14


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission